WallStSmart
VVOS

Vivos Therapeutics Inc

NASDAQ: VVOS · HEALTHCARE · MEDICAL DEVICES

$0.80
+2.26% today

Updated 2026-04-30

Market cap
$11.46M
P/E ratio
P/S ratio
0.66x
EPS (TTM)
$-2.07
Dividend yield
52W range
$1 – $8
Volume
0.2M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$2.42
+202.05%
12-Month target
Intrinsic (DCF)
$3.68
Margin of safety
+57.88%
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 57.88% below intrinsic value
Risks
- Thin margins at -121.40%
- Negative free cash flow $-4.71M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$16.02M$13.80M$15.03M$17.44M$17.44M
Net income$-23.84M$-13.58M$-11.14M$-21.23M$-6.95M
EPS$-2.07
Free cash flow$-20.51M$-12.75M$-13.26M$-17.60M$-4.71M
Profit margin-148.81%-98.42%-74.09%-121.71%-121.40%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
VVOS$11.46M234.02.06.75.0+57.88%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Vivos Therapeutics Inc trades at $0.80. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $17.44M. with profit margins at -121.40%. Our DCF model estimates intrinsic value at $3.68.

Frequently asked questions

What is Vivos Therapeutics Inc's stock price?
Vivos Therapeutics Inc (VVOS) trades at $0.80.
Is Vivos Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $3.68.
What is the price target of Vivos Therapeutics Inc (VVOS)?
The analyst target price is $2.42, representing +202.0% upside from the current price of $0.80.
What is the intrinsic value of Vivos Therapeutics Inc (VVOS)?
Based on our DCF model, intrinsic value is $3.68, a +57.9% margin of safety versus $0.80.
What is Vivos Therapeutics Inc's revenue?
TTM revenue is $17.44M.

Company info

SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.66x
ROE-663.00%
Beta6.90
50D MA$1.26
200D MA$2.63
Shares out0.01B
Float0.01B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years